Anti-B7-H1/PD-L1/CD274 Antibody (Garivulimab)
Catalog No.
F1135
Anti-B7-H1/PD-L1/CD274 Antibody (Garivulimab)
Featured Products
Garivulimab (BGB-A333) is a humanized IgG1 variant monoclonal antibody that specifically targets and binds to PD-L1. Garivulimab selectively blocks the interaction between PD-L1 and PD-1 and has anti-tumor activity.
Quality Control & DataSheet
- View current batch:
-
Purity > 95% by SDS-PAGE and SEC-HPLC analyses.
- MSDS (Material Safety Data Sheet)
- Datasheet
144.3 kDa
Dry ice
2342597-81-1
-80°C
2 years
Liquid
See label
For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.
CHO
BGB-A333
100 mM Pro 20 mM Arg pH 5.0. No preservative!
Q9NZQ7
Human
Unconjugated
Monoclonal
Protein A
IgG1
ELISA, FACS, Kinetics, Functional assay, Animal Model
B7-H1 / PD-L1 / CD274
Please avoid freeze-thaw cycles.